Microbiological Assessment of Bile in Patients Undergone to Endoscopic Retrograde Cholangiography (ERCP): the "Microbile Registry"

Launched by AZIENDA UNITÀ SANITARIA LOCALE DELLA ROMAGNA · Oct 30, 2023

Keywords

ClinConnect Summary

The "Microbile Registry" is a clinical trial that aims to study the types of bacteria present in the bile of patients who are undergoing a procedure called Endoscopic Retrograde Cholangiography (ERCP). This procedure is often used to treat conditions like jaundice, which is a yellowing of the skin and eyes caused by liver or bile duct issues, as well as other biliary diseases. By understanding the microbial environment in the bile, researchers hope to improve treatment options and patient outcomes.

To participate in this study, you must be at least 18 years old and able to give consent. You can join if you have a medical reason for needing an ERCP, whether it is for a benign (non-cancerous) or malignant (cancerous) condition. However, if you have previously had a specific surgery related to the bile ducts, are pregnant or breastfeeding, or cannot provide informed consent, you will not be eligible for this study. If you choose to participate, you can expect to have your bile assessed for bacteria during the ERCP procedure, which could help shape future treatments for similar conditions.

Gender

ALL

Eligibility criteria

• • Main inclusion criteria for patient enrollment were: ability to provide an informed consent; age \>/=18 years; any benignant or malignant ERCP indication.
• All subjects were excluded from the study:
• • Patients who have already undergone endoscopic sphincterotomy
• • Patients unable to express informed consent
• • Pregnant or breastfeeding women
• • Patients with anatomical post-surgical alterations of the upper gastrointestinal (GI) tract